athletes following anterior cruciate ligament reconstruction. Sprain of anterior cruciate ligament of knee
Conditions
Interventions
Intervention 1: treatment group: Whole body vibration and exercise therapy including resistive exercises and perturbation exercises for 12 sessions in 4 weeks. Intervention 2: Control group: exercise
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 18-40 years old both of gender lll More than 6 months have passed since the surgery Edinburgh handedness inventory (EHI) questionnaire Tegner Activity Level Scale < 8 Have a history of anterior cruciate ligament surgery (all types of graft) without surgery for other ligament and meniscus injuries had no pain, inflammation or limited range of motion in the knee joint WBV contraindication: pregnancy, acute thrombosis, serious cardiovascular disease, pacemaker, acute hernia, discopathy, spondylolysis, severe diabetes, epilepsy, recent infections, severe migraine, tumors or kidney stones. TMS contraindication: having a history of seizures, epilepsy (first-degree person or family), head injury or brain injury, having metal in the head (outside the mouth) such as a surgical clip, implantation Welded cochlear implants, history of a bad reaction to an MRI or TMS, history of stroke, brain-related diseases such as MS or brain tumor, history of fainting, severe headache, pregnancy Or planning for pregnancy in the past 3 months, taking medications known to lower the seizure threshold such as imipramine & …. Have a history of anterior cruciate ligament surgery (hamstring graft) without surgery for other ligament and meniscus injuries
Exclusion criteria
Exclusion criteria: Inability to understand and/or perform the required maneuvers. Alcohol, caffeine and drug consumption on the day of the test. Participant dissatisfaction with the continuation of the program. Presence of pain at the time of the tests or any complication preventing the data collection. Being absent for more than 2 sessions or for 3 times during the whole procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Central Activation Ratio. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Biodex & stimulator.;Active Motor Threshold. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Transcranial magnetic stimulation (MagPro X100).;Amplitude of Motor Evoked Potentials. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Transcranial magnetic stimulation (MagPro X100).;Map Volume of quadriceps muscle in motor cortex. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Transcranial magnetic stimulation (MagPro X100).;Center of Gravity of quadriceps muscle's map in motor cortex. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Transcranial magnetic stimulation (MagPro X100).;6m-Timed Hop Test Limb Symmetry Index. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using chronometer.;Disability in Activities of Daily Living. Timepoint: At the start of the study and 48 hours after end of the treatment. Method of measurement: By using Knee Outcome Survey Activities of Daily Living Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoya Khanmohammadi
Tehran University of Medical Sciences
Outcome results
None listed